Literature DB >> 7550052

Pharmacotherapy of insomnia: practice and prospects.

J Dingemanse1.   

Abstract

Insomnia is a complex complaint which is often multifactorial in origin. Pharmacotherapy can only be an adjunct in the treatment of insomnia and hypnotics should be given on an intermittent basis for short periods of time. An overview is presented of the currently available hypnotics, of which benzodiazepines are still the most widely prescribed. New drugs which bind to specific receptor subtypes or which are partial benzodiazepine receptor agonists might overcome the disadvantages associated with chronic benzodiazepine use, but more long-term investigations are needed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550052     DOI: 10.1007/bf01875434

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  101 in total

Review 1.  Appropriate use and regulatory control of benzodiazepines.

Authors:  R I Shader; D J Greenblatt; M B Balter
Journal:  J Clin Pharmacol       Date:  1991-09       Impact factor: 3.126

Review 2.  Hypnotics. Their place in therapeutics.

Authors:  A N Nicholson
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

Review 3.  Criteria for selection of appropriate benzodiazepine hypnotic therapy.

Authors:  J Mendels
Journal:  J Clin Psychiatry       Date:  1991-09       Impact factor: 4.384

4.  The nuts and bolts of behavioral therapy for insomnia.

Authors:  E P Sloan; P Hauri; R Bootzin; C Morin; M Stevenson; C M Shapiro
Journal:  J Psychosom Res       Date:  1993       Impact factor: 3.006

5.  A review of the utilization of sedative-hypnotic drugs in a general hospital.

Authors:  D A Picone; D A D'Mello; M L Foote; B Msibi
Journal:  Gen Hosp Psychiatry       Date:  1993-01       Impact factor: 3.238

6.  Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as omega receptor subtypes.

Authors:  S Z Langer; S Arbilla
Journal:  Pharmacol Biochem Behav       Date:  1988-04       Impact factor: 3.533

Review 7.  Comparative clinical profiles of triazolam versus other shorter-acting hypnotics.

Authors:  J M Jonas; B S Coleman; A Q Sheridan; R W Kalinske
Journal:  J Clin Psychiatry       Date:  1992-12       Impact factor: 4.384

Review 8.  The proper use of sleeping pills in the primary care setting.

Authors:  W C Dement
Journal:  J Clin Psychiatry       Date:  1992-12       Impact factor: 4.384

9.  [Contribution of zolpidem in the management of sleep disorders].

Authors:  J Lavoisy; B Zivkovic; J Benavides; G H Perrault; P Robert
Journal:  Encephale       Date:  1992 Jul-Aug       Impact factor: 1.291

10.  Indole-3-pyruvic acid as a possible hypnotic agent in insomniac subjects.

Authors:  R Silvestri; G Mento; M Raffaele; G De Luca; G Buttini; C Casella; A Tisano; P De Domenico; A E Di Rosa; R Di Perri
Journal:  J Int Med Res       Date:  1991 Sep-Oct       Impact factor: 1.671

View more
  3 in total

1.  Hypnotics. Drug selection by means of the System of Objectified Judgement Analysis (SOJA) method.

Authors:  R Janknegt; A van der Kuy; G Declerck; C Idzikowski
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

2.  Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects.

Authors:  J Dingemanse; M Bury; J Bock; P Joubert
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

Review 3.  Zopiclone. An update of its pharmacology, clinical efficacy and tolerability in the treatment of insomnia.

Authors:  S Noble; H D Langtry; H M Lamb
Journal:  Drugs       Date:  1998-02       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.